ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC

Clinical trial NCT06351332 · TERMINATED

Trial details

NCT number: NCT06351332
Sponsor: Filipa Lynce, MD
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Breast Cancer Female Triple Negative Breast Cancer Hormone Receptor Negative Malignant Tumor Breast Triple HER2-negative Breast Cancer

Start date: 2024-05-01
Primary completion: 2026-02-24
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.